People with hepatitis C virus who inject drugs could be evaluated for cure approximately 2 months earlier than current ...

Researchers at the University of Washington have developed a rapid test that quickly detects hepatitis C, but insurance ...

Phase 3 Topline Results for Potential Best-in-Class Regimen for Treatment of HCV on Track for 2026Topline Results from North American Phase 3 ...

AbbVie (NYSE: ABBV) announced today that Health Canada has approved MAVIRET (glecaprevir/pibrentasvir tablets) for the treatment of acute and chronic hepatitis C virus (HCV) infection in adults and ...

Please provide your email address to receive an email when new articles are posted on . Among 133,732 veterans with HCV, 80.1% initiated treatment and 91.6% achieved SVR. Younger veterans were less ...

A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use ...

Enrollment Completed in C-BEYOND Phase 3 Trial with More Than 880 HCV Treatment-Naïve Patients in US and CanadaC-BEYOND Topline Results Expected ...

Pregnant individuals with syphilis and HCV coinfection had higher rates of congenital syphilis outcomes compared with those without HCV.

People coinfected with HIV and hepatitis C virus remain at risk for hepatocellular carcinoma within 6 years of starting ...

When managing patients with hepatitis C virus (HCV), initiating treatment of the infection promptly is more important than determining the severity of their liver disease with the customary staging ...

Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...